LncRNA GAS5 is down-regulated in cardiomyocytes with diabetic cardiomyopathy (DCM), and its overexpression suppresses the expression of NLRP3 and its downstream genes and caspase-1 activity, thus improving DCM [57]. This evidence concerns the gene NLRP3 and diabetic cardiomyopathy.